SUSTAINED SYMPTOM CONTROL WITH LANREOTIDE DEPOT IN CARCINOID SYNDROME (CS) IN NEUROENDOCRINE TUMOR PATIENTS: FOLLOW-UP ANALYSIS OF THE ELECT PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND AND OPEN-LABEL PHASES.

SUSTAINED SYMPTOM CONTROL WITH LANREOTIDE DEPOT IN CARCINOID SYNDROME (CS) IN NEUROENDOCRINE TUMOR PATIENTS: FOLLOW-UP ANALYSIS OF THE ELECT PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND AND OPEN-LABEL PHASES. Meeting Abstract

authors

Vinik, Aaron I.

publication date

March 1, 2017

webpage

Web of Science

published in

ONCOLOGY NURSING FORUM Journal

volume

44

issue

2